发明名称 |
Hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension |
摘要 |
The current invention relates to the field of hypoxia-induced disorders and more specifically to the use of hypoxia inducible factor 2alpha as a target in a method for the screening for molecules that can be used for the treatment of pulmonary hypertension. The invention further relates to the use of HIF-2alpha and/or of the HIF-2alpha inducible protein VEGF for the treatment of neonatal respiratory distress syndrome.
|
申请公布号 |
US7307060(B2) |
申请公布日期 |
2007.12.11 |
申请号 |
US20050226771 |
申请日期 |
2005.09.14 |
申请人 |
VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW |
发明人 |
COMPERNOLLE VEERLE;CARMELIET PETER |
分类号 |
A61K38/00;G01N33/74 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|